Researchers at the University of South Florida have developed a comprehensive framework to test how accurately AI systems can ...
Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...
Flow Pharma, Inc. announced today that it's U.S. Patent application has been allowed for issuance covering a broad-spectrum treatment for Ebola virus infections, utilizing the company's proprietary ...
COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will announce the ...
CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand ...
The first ever avian influenza vaccine recently started trials in the UK. This marks a milestone in the prevention of bird ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
The global In Silico Clinical Trials market offers significant opportunities due to the growing demand for faster drug ...
13d
Cloud-Clone Advances Global Antibody Solutions for Life Science Research and In Vitro Diagnostics
Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...
Editing a small number of blood-forming stem cells to encode powerful antibodies turns the immune system into a living drug ...
Flow Pharma, Inc. announced today that it's U.S. Patent application has been allowed for issuance covering a broad-spectrum treatment for Ebola virus infections, utilizing the company's proprietary mi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results